Blueprint Biosecurity advances pathogen-agnostic pandemic countermeasures through research, strategic grantmaking, and policy guidance, focusing on respiratory protection and indoor air treatment.

Products & media

Respiratory Protection

Research and preparedness program supporting respirator availability, emergency stockpiling, surge manufacturing, and effective use by critical workers.

Glycol Vapors

Research program assessing glycol vapors for indoor pathogen control, including safety, effectiveness, and potential emergency deployment in occupied spaces.

Far-UVC

Research program evaluating far-UVC safety, effectiveness, regulatory requirements, and deployment considerations for reducing airborne pathogens in occupied indoor spaces.

Conventional GUV

Program supporting adoption of conventional germicidal ultraviolet air treatment, with attention to standards and scalable indoor pathogen mitigation.

Team

1 person across company lists

Founders

1 person

List